KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Net Margin (2017 - 2026)

Guardant Health's Net Margin history spans 9 years, with the latest figure at 45.68% for Q4 2025.

  • On a quarterly basis, Net Margin rose 932.0% to 45.68% in Q4 2025 year-over-year; TTM through Dec 2025 was 42.39%, a 1666.0% increase, with the full-year FY2025 number at 42.39%, up 1666.0% from a year prior.
  • Net Margin hit 45.68% in Q4 2025 for Guardant Health, down from 34.96% in the prior quarter.
  • Over the last five years, Net Margin for GH hit a ceiling of 34.96% in Q3 2025 and a floor of 210.21% in Q2 2022.
  • Historically, Net Margin has averaged 88.76% across 5 years, with a median of 76.17% in 2024.
  • Biggest five-year swings in Net Margin: tumbled -10427bps in 2022 and later skyrocketed 15715bps in 2023.
  • Tracing GH's Net Margin over 5 years: stood at 84.09% in 2021, then crashed by -31bps to 110.28% in 2022, then dropped by -9bps to 120.63% in 2023, then surged by 54bps to 55.0% in 2024, then increased by 17bps to 45.68% in 2025.
  • Business Quant data shows Net Margin for GH at 45.68% in Q4 2025, 34.96% in Q3 2025, and 43.04% in Q2 2025.